Top compounds associated with response to RP13-210D15.9


Feature Type Standardized
Nominal ANOVA
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.0064 0.9
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.005 0.9
mRNA YM-155 CTRPv2 pan-cancer AAC -0.0057 0.9
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.0064 0.9
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.0047 0.9
mRNA KU 0060648 CTRPv2 pan-cancer AAC 0.0051 0.9
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0049 0.9
mRNA tigecycline CTRPv2 pan-cancer AAC -0.0069 0.9
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.0039 0.9
mRNA leptomycin B CTRPv2 pan-cancer AAC 0.0046 0.9
Download CSV